For the spray, one dose twice daily with 30-60 seconds of sublingual holding is recommended
A glucagon-like peptide-1 receptor agonist, semaglutide, mimics the action of a natural hormone called GLP-1, reducing blood sugar levels by stimulating insulin secretion and reducing glucagon secretion
Two separate insurance situations
In addition to obesity therapy (discussed next), immunology medicine use grew substantially in the past year as IQVIA observed more patients across a broader range of autoimmune and inflammatory diseases gained access to new medicines
However, as with all medications, individual responses can vary, and ongoing pharmacovigilance continues to monitor for any emerging safety concerns
However, insufficient evidence exists to justify the discontinuation of GLP-1 RAs before the procedure, and the ideal cessation timing for these agents remains indeterminate